tirzepatide surmount SURMOUNT-2: Demonstrates Body Weight-Lowering Effects in T2D Tirzepatide for the Treatment of

The faster initial loss in men relates to higher baseline metabolic rates, more visceral fat (which mobilizes readily), and absence of menstrual cycle water fluctuations that can mask fat loss in women

Providers note that patients achieve gradual, sustainable weight reduction while maintaining improved glycemic control

Yes, anecdotal evidence and social media analyses suggest sleep disruption is a common experience for many users

Hyponatraemia (low sodium) is a recognised risk with SSRIs like escitalopram, which may be compounded by dehydration from GLP-1related gastrointestinal effects

Titration with medicines such as Semaglutide is an important part of the weight loss, as studies show that higher doses yield better results in terms of weight loss

By the end of week 1, some individuals notice their usual portion sizes feel uncomfortable or too large